clinical trial · NCT06769191
Clinical Study on the Safety and Efficacy of CD7 CAR-T Cell Sequential Allo-HSCT and Kidney Transplantation in the Treatment of SIOD
Zhejiang University·early phase1·recruiting·n = 20
Schimke Immuno-osseous DysplasiaCD7 CAR-T cells injectionAllo-HSCTKidney Transplantation
brief summary
A Clinical Study on the Safety and Effectiveness of CD7 CAR-T Cell Sequential Allo-HSCT and Kidney Transplantation in the treatment of Schimke immuno-osseous dysplasia
started
Jan 30, 2025
primary completion
Jan 30, 2028
completion
Jan 30, 2028
last updated
Jan 20, 2025
detailed description
This is a single-arm, open-label, dose-escalation clinical trial to evaluate the safety and efficacy of CD7 CAR-T Cell Sequential Allo-HSCT and Kidney Transplantation in patients with Schimke immuno-osseous dysplasia. It is planned to enroll 20 participants in this trial.
official title
Clinical Study on the Safety and Efficacy of CD7 CAR-T Cell Sequential Allogeneic Hematopoietic Stem Cell Transplantation and Kidney Transplantation in the Treatment of Schimke Immuno-osseous Dysplasia
sourced from ClinicalTrials.gov · pharmadog mirrors structured fields, not the full protocol